Suchergebnisse - "Fetterly, Gerald"

PubPharm (105)

1

Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis : A Randomized Clinical Trial

enthalten in: JAMA dermatology | 2024

von Eichenfield, L. | Tarabar, S. | Forman, S. | +7

2

Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis : a phase IIb randomized double-blind vehicle-controlled parallel-group study

enthalten in: The British journal of dermatology | 2023

von Landis, M. | Smith, S. | Berstein, G. | +10

CommentIn: Br J Dermatol. 2023 May 08;:. - PMID 37151092

3

A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia

enthalten in: Investigational new drugs | 2022

von Kasner, M. | Halloran, M. | Pan, J. | +5

4

A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia

enthalten in: Investigational new drugs | 2022

von Kasner, M. | Halloran, M. | Pan, J. | +5

5

A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia

enthalten in: Investigational new drugs | 2022

von Kasner, M. | Halloran, M. | Pan, J. | +5

6

A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia

enthalten in: Investigational new drugs | 2022

von Kasner, M. | Halloran, M. | Pan, J. | +5

7

A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia

enthalten in: ResearchSquare.com | 2022

von Kasner, M. | Halloran, M. | Pan, J. | +5

8

Dose-Dependent Sorafenib-Induced Immunosuppression Is Associated with Aberrant NFAT Activation and Expression of PD-1 in T Cells

enthalten in: Cancers | 2019

von Iyer, R. | Maguire, O. | Kim, M. | +7

9

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients

enthalten in: American journal of clinical oncology | 2019

von Ma, W. | Xie, H. | Fetterly, G. | +13

10

A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies

enthalten in: Cancer | 2018

von Fountzilas, C. | Javle, M. | Tan, W. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]